Simonsen U, Prieto D, Nyborg N C, Mulvany M J
Department of Pharmacology, University of Aarhus, Denmark.
J Pharm Pharmacol. 1996 Jun;48(6):607-14. doi: 10.1111/j.2042-7158.1996.tb05982.x.
Anti-hypertensive treatment is much less successful at reducing coronary artery disease than at reducing mortality from stroke and congestive heart failure. The effects of the alpha-adrenergic antagonist doxazosin on progression of atheromatous lesions and functional responses of isolated coronary arteries from cholesterol-fed rabbits have been investigated. Normotensive rabbits were fed either a standard chow (control, n = 8) or a 1% cholesterol-rich diet (n = 16) for 20 weeks. After 3 weeks the cholesterol-fed animals were assigned randomly to two groups either given placebo capsules (n = 8) or treated with doxazosin (5 mg kg-1 day-1; n = 8). Doxazosin reduced the mean arterial blood pressure by 10% that of the control and placebo-treated cholesterol-fed rabbits, but did not affect the plasma cholesterol, triacylglycerol and phospholipid levels, which were, after 20 weeks, severalfold increased in the cholesterol-fed rabbits compared with controls. Histological examination showed atheromatous lesions in proximal (but not distal) coronary arteries from both groups of cholesterol-fed rabbits. Doxazosin either had no effect on reduced contractions to 125 mmol L-1 potassium saline solution or increased contractions to 5-hydroxytryptamine in proximal isolated coronary arteries from the cholesterol-fed rabbits. It did, however, abolish the hyper-responsiveness of the large atheromatous coronary arteries to noradrenaline. In both vehicle-and doxazosin-treated cholesterol-fed rabbits the maximum relaxation and sensitivity to acetylcholine were significantly reduced in proximal segments compared with the control group, whereas responses to acetylcholine in distal coronary segments were not significantly different. The relaxation to sodium nitroprusside, adenosine diphosphate and isoprenaline in proximal and distal coronary arteries were similar in the three experimental groups. These results indicate that treatment of normotensive cholesterol-fed rabbits with doxazosin prevents the hyper-responsiveness to noradrenaline of proximal coronary arteries, although it does not prevent the progression of other functional alterations observed in the coronary circulation.
抗高血压治疗在降低冠状动脉疾病方面远不如在降低中风和充血性心力衰竭死亡率方面成功。研究了α-肾上腺素能拮抗剂多沙唑嗪对高胆固醇喂养兔动脉粥样硬化病变进展和离体冠状动脉功能反应的影响。将血压正常的兔子分为两组,一组喂食标准饲料(对照组,n = 8),另一组喂食富含1%胆固醇的饲料(n = 16),持续20周。3周后,将喂食胆固醇的动物随机分为两组,一组给予安慰剂胶囊(n = 8),另一组用多沙唑嗪治疗(5 mg·kg-1·天-1;n = 8)。多沙唑嗪使平均动脉血压降低至对照组和给予安慰剂的高胆固醇喂养兔的10%,但不影响血浆胆固醇、三酰甘油和磷脂水平,20周后,高胆固醇喂养兔的这些指标与对照组相比增加了数倍。组织学检查显示,两组高胆固醇喂养兔近端(而非远端)冠状动脉均有动脉粥样硬化病变。多沙唑嗪对高胆固醇喂养兔离体近端冠状动脉对125 mmol·L-1氯化钾溶液的收缩反应降低没有影响,或使对5-羟色胺的收缩反应增加。然而,它确实消除了大的动脉粥样硬化冠状动脉对去甲肾上腺素的高反应性。在给予载体和多沙唑嗪治疗的高胆固醇喂养兔中,近端节段对乙酰胆碱的最大舒张和敏感性与对照组相比均显著降低,而远端冠状动脉节段对乙酰胆碱的反应无显著差异。三组实验中,近端和远端冠状动脉对硝普钠、二磷酸腺苷和异丙肾上腺素的舒张反应相似。这些结果表明,用多沙唑嗪治疗血压正常的高胆固醇喂养兔可预防近端冠状动脉对去甲肾上腺素的高反应性,尽管它不能阻止在冠状动脉循环中观察到的其他功能改变的进展。